Exact Sciences
EXAS
EXAS was delisted on the 20th of March, 2026.
600 hedge funds and large institutions have $12.4B invested in Exact Sciences in 2024 Q3 according to their latest regulatory filings, with 119 funds opening new positions, 170 increasing their positions, 200 reducing their positions, and 56 closing their positions.
125% more funds holding in top 10
Funds holding in top 10: 4 → 9 (+5)
113% more first-time investments, than exits
New positions opened: 119 | Existing positions closed: 56
64% more capital invested
Capital invested by funds: $7.57B → $12.4B (+$4.87B)
15% more call options, than puts
Call options by funds: $194M | Put options by funds: $169M
10% more funds holding
Funds holding: 544 → 600 (+56)
1.89% more ownership
Funds ownership: 97.03% → 98.93% (+1.9%)
15% less repeat investments, than reductions
Existing positions increased: 170 | Existing positions reduced: 200
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$453M |
| 2 |
Ameriprise
Minneapolis,
Minnesota
|
+$130M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$119M |
| 4 |
Mackenzie Financial
Toronto Ontario,
Ontario, Canada
|
+$78.7M |
| 5 |
JP Morgan Chase
New York
|
+$51.6M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Holocene Advisors
New York
|
-$122M |
| 2 |
State Street
Boston,
Massachusetts
|
-$86.3M |
| 3 |
AC
Armistice Capital
New York
|
-$59.2M |
| 4 |
B
Braidwell
Stamford,
Connecticut
|
-$48.3M |
| 5 |
BlackRock
New York
|
-$45M |
EXAS Hedge Fund Activity: Q3 2024 in Review
600 of the 6,967 institutional investors tracked by Wall St. Rank reported a position in Exact Sciences (EXAS) for Q3 2024, worth a combined $12.4B — up 64% from $7.57B a quarter earlier.
Buyers outnumbered sellers: 119 funds opened new EXAS positions and 56 closed out — a net gain of 63 holders — while 170 added to existing stakes and 200 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $453M. The largest seller was Holocene Advisors, cutting an estimated $122M.
- 600 institutional investors held Exact Sciences (EXAS) as of Q3 2024, up from 544 in Q2 2024.
- Funds reported $12.4B of Exact Sciences stock for Q3 2024, up 64% quarter-over-quarter.
- 119 funds opened new Exact Sciences positions in Q3 2024 and 56 closed out, a net change of +63 holders.
- The largest Exact Sciences buyer in Q3 2024 was Fidelity Investments, an estimated $453M added.
- The largest Exact Sciences seller in Q3 2024 was Holocene Advisors, an estimated $122M sold.
Based on aggregated 13F filings for Q3 2024.